Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita - 11/09/11
Résumé |
Epidermolysis bullosa acquisita is an uncommon autoimmune bullous disease of the skin and mucous membranes. It is chronic, disabling, and difficult to treat. We describe a case of se- vere epidermolysis bullosa acquisita of 7 years' duration that had been treated with azathi- oprine, corticosteroids, chlorambucil, plasma exchanges, cyclophosphamide, cyclosporine, and colchicine without any lasting effect. Seven cycles of treatment were administered with immunoglobulin given intravenously at a low dose, 40 mg/kg body weight daily for 5 days. The patient was free of disease for 10 months after the initiation of therapy. We suggest that low-dose regimens of immunoglobulins may be as effective in this disease as the high-dose regimens suggested in the literature, and at much lower cost.
Le texte complet de cet article est disponible en PDF. This article is made possible through an educational grant from the Dermatological Division, Ortho Pharmaceutical Corporation. |
Vol 36 - N° 2P2
P. 331-335 - février 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?